An immunoproteomic approach to identifying immunoreactive proteins in Leishmania infantum amastigotes using sera of dogs infected with canine visceral leishmaniasis

References

• Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol. 2002;9(5):951–958.
   PubMedGoogle Scholar
• Russo R, Laguna F, Lopez-Velez R, et al. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections. Ann Trop Med Parasitol. 2003;97(sup1):99–105.
   PubMed Web of Science ®Google Scholar
• Alvar J, Aparicio P, Aseffa A, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev. 2008;21(2):334–359.
   PubMed Web of Science ®Google Scholar
• Jain K, Jain N. Vaccines for visceral leishmaniasis: A review. J Immunol Methods. 2015;422:1–12.
   PubMed Web of Science ®Google Scholar
• Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Rev Microbiol. 2007;5(11supp):S7.
   Google Scholar
• Gillespie PM, Beaumier CM, Strych U, et al. Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016;34(26):2992–2995.
   PubMed Web of Science ®Google Scholar
• Mutiso JM, Macharia JC, Kiio MN, et al. Development of Leishmania vaccines: predicting the future from past and present experience. J Biomed Res. 2013;27(2):85.
   PubMedGoogle Scholar
• Roatt BM, Aguiar-Soares R, Reis LES, et al. A vaccine therapy for canine visceral leishmaniasis promoted significant improvement of clinical and immune status with reduction in parasite burden. Front Immunol. 2017;8:217.
   PubMed Web of Science ®Google Scholar
• Cantacessi C, Dantas-Torres F, Nolan MJ, et al. The past, present, and future of Leishmania genomics and transcriptomics. Trends Parasitol. 2015;31(3):100–108.
   PubMed Web of Science ®Google Scholar
• Kumari S, Kumar A, Samant M, et al. Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics. Curr Drug Targets. 2008;9(11):938–947.
   PubMed Web of Science ®Google Scholar
• Furman D, Davis MM. New approaches to understanding the immune response to vaccination and infection. Vaccine. 2015;33(40):5271–5281.
   PubMed Web of Science ®Google Scholar
• Lima B, Fialho L Jr, Pires S, et al. Immunoproteomic and bioinformatic approaches to identify secreted Leishmania amazonensis, L. braziliensis, and L. infantum proteins with specific reactivity using canine serum. Vet Parasitol. 2016;223:115–119.
   PubMed Web of Science ®Google Scholar
• Ejazi SA, Bhattacharyya A, Choudhury ST, et al. Immunoproteomic identification and characterization of leishmania membrane proteins as non-invasive diagnostic candidates for clinical visceral leishmaniasis. Sci Rep. 2018;8(1):12110.
   PubMedGoogle Scholar
• Forgber M, Basu R, Roychoudhury K, et al. Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology. PloS One. 2006;1(1):e40.
   PubMed Web of Science ®Google Scholar
• Rochette A, Raymond F, Corbeil J, et al. Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum. Mol Biochem Parasitol. 2009;165(1):32–47.
   PubMed Web of Science ®Google Scholar
• Dea‐Ayuela MA, Rama‐Iñiguez S, Bolás‐Fernández F. Proteomic analysis of antigens from Leishmania infantum promastigotes. Proteomics. 2006;6(14):4187–4194.
   PubMed Web of Science ®Google Scholar
• Lynn MA, Marr AK, McMaster WR. Differential quantitative proteomic profiling of Leishmania infantum and Leishmania mexicana density gradient separated membranous fractions. J Proteomics. 2013;82:179–192.
   PubMed Web of Science ®Google Scholar
• Lima B, Pires S, Fialho L Jr, et al. A proteomic road to acquire an accurate serological diagnosis for human tegumentary leishmaniasis. J Proteomics. 2017;151:174–181.
   PubMed Web of Science ®Google Scholar
• Rashidi S, Kalantar K, Hatam G. Achievement amastigotes of Leishmania infantum and investigation of pathological changes in the tissues of infected golden hamsters. J Parasit Dis. 2018;42(2):187–195.
   PubMedGoogle Scholar
• Costa MM, Andrade HM, Bartholomeu DC, et al. Analysis of Leishmania chagasi by 2-D difference gel eletrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine. J Proteome Res. 2011;10(5):2172–2184.
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci. 1979;76(9):4350–4354.
   PubMed Web of Science ®Google Scholar
• Mojtahedi Z, Clos J, Kamali-Sarvestani E. Leishmania major: identification of developmentally regulated proteins in procyclic and metacyclic promastigotes. Exp Parasitol. 2008;119(3):422–429.
   PubMed Web of Science ®Google Scholar
• Brandau S, Dresel A, Clos J. High constitutive levels of heat-shock proteins in human-pathogenic parasites of the genus Leishmania. Biochem J. 1995;310(1):225–232.
   PubMedGoogle Scholar
• Pérez-Morales D, Espinoza B. The role of small heat shock proteins in parasites. Cell Stress Chaperones. 2015;20(5):767–780.
   PubMed Web of Science ®Google Scholar
• Hombach A, Ommen G, MacDonald A, et al. A small heat shock protein is essential for thermotolerance and intracellular survival of Leishmania donovani. J Cell Sci. 2014;127(21):4762–4773.
   PubMed Web of Science ®Google Scholar
• DA SILVA EC R, Cd MOURAPMF, Andrade PP. Partial purification, immunogenicity and putative new localization of a native Leishmania heat shock protein 70. Parasitología Latinoam. 2008;63(1–2–3–4):4–11.
   Google Scholar
• Moreira MEC, Del Portillo HA, Milder RV, et al. Heat shock induction of apoptosis in promastigotes of the unicellular organism Leishmania (Leishmania) amazonensis. J Cell Physiol. 1996;167(2):305–313.
   PubMed Web of Science ®Google Scholar
• Requena JM, Montalvo AM, Fraga J. Molecular chaperones of Leishmania: central players in many stress-related and-unrelated physiological processes. Biomed Res Int. 2015;2015.
   PubMedGoogle Scholar
• Horwich A, Hartl F, Cheng M. Role of HSP60 in folding/assembly of mitochondrial proteins. In: Heat Shock. Berlin: Springer; 1991. p. 165–173.
   Google Scholar
• Colineau L, Clos J, Moon K-M, et al. Leishmania donovani chaperonin 10 regulates parasite internalization and intracellular survival in human macrophages. Med Microbiol Immunol. 2017;206(3):235–257.
   PubMed Web of Science ®Google Scholar
• Alexandratos A, Clos J, Samiotaki M, et al. The loss of virulence of histone H 1 overexpressing L eishmania donovani parasites is directly associated with a reduction of HSP 83 rate of translation. Mol Microbiol. 2013;88(5):1015–1031.
   PubMed Web of Science ®Google Scholar
• Okwor I, Uzonna J. Vaccines and vaccination strategies against human cutaneous leishmaniasis. Hum Vaccines. 2009;5(5):291–301.
   PubMed Web of Science ®Google Scholar
• Celeste B, Angel SO, Castro L, et al. Leishmania infantum heat shock protein 83 for the serodiagnosis of tegumentary leishmaniasis. Braz J Med Biol Res. 2004;37(11):1591–1593.
   PubMed Web of Science ®Google Scholar
• Montalvo-Álvarez AM, Folgueira C, Carrión J, et al. The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infection. Biomed Res Int. 2008;2008. DOI: 10.1155/2008/695432
   Google Scholar
• Rey-Ladino JA, Joshi PB, Singh B, et al. Leishmania major: molecular cloning, sequencing, and expression of theheat shock protein 60Gene reveals unique carboxy terminal peptide sequences. Exp Parasitol. 1997;85(3):249–263.
   PubMed Web of Science ®Google Scholar
• Muta T, Kang D, Kitajima S, et al. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem. 1997;272(39):24363–24370.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Peerschke EI. Structure and function of gC1q-R: a multiligand binding cellular protein. Immunobiology. 1998;199(2):225–238.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Lim B-L, Peerschke E, et al. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular” heads” of C1q. J Exp Med. 1994;179(6):1809–1821.
   PubMed Web of Science ®Google Scholar
• Feng X, Feistel T, Buffalo C, et al. Remodeling of protein and mRNA expression in Leishmania mexicana induced by deletion of glucose transporter genes. Mol Biochem Parasitol. 2011;175(1):39–48.
   PubMed Web of Science ®Google Scholar
• Chavali AK, Whittemore JD, Eddy JA, et al. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol. 2008;4(1):177.
   PubMedGoogle Scholar
• Bringaud F, Peris M, Zen KH, et al. Characterization of two nuclear-encoded protein components of mitochondrial ribonucleoprotein complexes from Leishmania tarentolae. Mol Biochem Parasitol. 1995;71(1):65–79.
   PubMed Web of Science ®Google Scholar
• Brocker C, Lassen N, Estey T, et al. Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress. J Biol Chem. 2010;285(24):18452–18463.
   PubMed Web of Science ®Google Scholar
• Magalhães RD, Duarte MC, Mattos EC, et al. Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites. PLoS Negl Trop Dis. 2014;8(4):e2764.
   PubMed Web of Science ®Google Scholar
• Saxena A, Lahav T, Holland N, et al. Analysis of the Leishmania donovani transcriptome reveals an ordered progression of transient and permanent changes in gene expression during differentiation. Mol Biochem Parasitol. 2007;152(1):53–65.
   PubMed Web of Science ®Google Scholar
• Clay MR, Tabor M, Owen JH, et al. Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 2010;32(9):1195–1201.
   PubMed Web of Science ®Google Scholar
• Jardim A, Hanson S, Ullman B, et al. Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11. Biochem J. 1995;305(1):315–320.
   PubMedGoogle Scholar
• Gwynne J, Brewer H, Edelhoch H. The molecular behavior of apoA-I in human high density lipoproteins. J Biol Chem. 1975;250(6):2269–2274.
   PubMed Web of Science ®Google Scholar
• Berberich C, Requena JM, Alonso C. Cloning of genes and expression and antigenicity analysis of theleishmania infantumKMP-11 Protein. Exp Parasitol. 1997;85(1):105–108.
   PubMedGoogle Scholar
• Jardim A, Funk V, Caprioli R, et al. Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein. Biochem J. 1995;305(1):307–313.
   PubMedGoogle Scholar
• Fuertes MA, Berberich C, Lozano RM, et al. Folding stability of the kinetoplastid membrane protein‐11 (KMP‐11) from Leishmania infantum. Eur J Biochem. 1999;260(2):559–567.
   PubMedGoogle Scholar
• Lugli EB, Pouliot M, MdPM P, et al. Characterization of primate trypanosome lytic factors. Mol Biochem Parasitol. 2004;138(1):9–20.
   PubMed Web of Science ®Google Scholar
• Blattner J, Swinkels B, Dörsam H, et al. Glycosome assembly in trypanosomes: variations in the acceptable degeneracy of a COOH-terminal microbody targeting signal. J Cell Biol. 1992;119(5):1129–1136.
   PubMed Web of Science ®Google Scholar
• McKoy G, Badal M, Prescott Q, et al. Characterisation of phosphoglycerate kinase genes in Leishmania major and evidence for the absence of a third closely related gene or isoenzyme. Mol Biochem Parasitol. 1997;90(1):169–181.
   PubMed Web of Science ®Google Scholar
• Blattner J, Helfert S, Michels P, et al. Compartmentation of phosphoglycerate kinase in Trypanosoma brucei plays a critical role in parasite energy metabolism. Proc Nat Acad Sci. 1998;95(20):11596–11600.
   PubMed Web of Science ®Google Scholar
• Azevedo A, Toledo JS, Defina T, et al. Leishmania major phosphoglycerate kinase transcript and protein stability contributes to differences in isoform expression levels. Exp Parasitol. 2015;159:222–226.
   PubMed Web of Science ®Google Scholar
• Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, et al. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol. 2013;135(2):344–349.
   PubMed Web of Science ®Google Scholar
• Ben NK, De GM, Louzir H, et al. Leishmania major protein disulfide isomerase as a drug target: enzymatic and functional characterization. Parasitol Res. 2012;110(5):1911–1917.
   PubMed Web of Science ®Google Scholar
• Amit A, Chaudhary R, Yadav A, et al. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis. Cell Immunol. 2014;289(1–2):76–85.
   PubMed Web of Science ®Google Scholar
• Naidoo N. ER and aging—protein folding and the ER stress response. Ageing Res Rev. 2009;8(3):150–159.
   PubMed Web of Science ®Google Scholar
• Hong B, Soong L. Identification and enzymatic activities of four protein disulfide isomerase (PDI) isoforms of Leishmania amazonensis. Parasitol Res. 2008;102(3):437–446.
   PubMed Web of Science ®Google Scholar
• Jaiswal AK, Khare P, Joshi S, et al. Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis. PLoS One. 2014;9(9):e108556.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Sisodia BS, Sinha S, et al. Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes. Proteomics. 2007;7(5):816–823.
   PubMed Web of Science ®Google Scholar
• Amit A, Dikhit MR, Singh AK, et al. Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice. Mol Immunol. 2017;82:104–113.
   PubMed Web of Science ®Google Scholar
• Joshi S, Yadav NK, Rawat K, et al. Immunogenicity and protective efficacy of T-cell epitopes derived from potential Th1 stimulatory proteins of Leishmania (Leishmania) donovani. Front Immunol. 2019;10. DOI:10.3389/fimmu/2019.00288
   Web of Science ®Google Scholar
• Kushawaha PK, Gupta R, Tripathi CDP, et al. Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis. PLoS One. 2012;7(4):e35670.
   PubMed Web of Science ®Google Scholar
• Achour YB, Chenik M, Louzir H, et al. Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor. Infect Immun. 2002;70(7):3576–3585.
   PubMed Web of Science ®Google Scholar
• Khalaf NB, De Muylder G, Louzir H, et al. Leishmania major protein disulfide isomerase as a drug target. Parasitol Res. 2012;110(5):1911–1917.
   PubMed Web of Science ®Google Scholar
• Grewal T, Enrich C. Annexins—modulators of EGF receptor signalling and trafficking. Cell Signal. 2009;21(6):847–858.
   PubMed Web of Science ®Google Scholar
• Siever DA, Erickson HP. Extracellular annexin II. Int J Biochem Cell Biol. 1997;29(11):1219–1223.
   PubMed Web of Science ®Google Scholar
• Wasmuth J, Daub J, Peregrín-Alvarez JM, et al. The origins of apicomplexan sequence innovation. Genome Res. 2009;19(7):1202–1213.
   PubMed Web of Science ®Google Scholar
• van Zandbergen G, Bollinger A, Wenzel A, et al. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Nat Acad Sci. 2006;103(37):13837–13842.
   PubMed Web of Science ®Google Scholar
• HALd S, GSd L, Boité MC, et al. Expression of annexin A1 in Leishmania-infected skin and its correlation with histopathological features. Rev Soc Bras Med Trop. 2015;48(5):560–567.
   PubMed Web of Science ®Google Scholar
• Oliveira LG, Souza-Testasicca MC, Vago JP, et al. Annexin A1 is involved in the resolution of inflammatory responses during Leishmania braziliensis infection. J Immunol. 2017;198(8):3227–3236.
   PubMed Web of Science ®Google Scholar
• Perretti M, Christian H, Wheller SK, et al. Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis. Cell Biol Int. 2000;24(3):163–174.
   PubMed Web of Science ®Google Scholar
• Perretti M, Gavins FN. Annexin 1: an endogenous anti-inflammatory protein. Physiology. 2003;18(2):60–64.
   Google Scholar
• Hofmann A, Osman A, Leow CY, et al. Parasite annexins–new molecules with potential for drug and vaccine development. Bioessays. 2010;32(11):967–976.
   PubMed Web of Science ®Google Scholar
• Berger LC, Wilson J, Wood P, et al. Methionine regeneration and aspartate aminotransferase in parasitic protozoa. J Bacteriol. 2001;183(15):4421–4434.
   PubMed Web of Science ®Google Scholar
• Vernal J, Cazzulo JJ, Nowicki C. Isolation and partial characterization of a broad specificity aminotransferase from Leishmania mexicana promastigotes. Mol Biochem Parasitol. 1998;96(1–2):83–92.
   PubMed Web of Science ®Google Scholar
• Gafan C, Wilson J, Berger LC, et al. Characterization of the ornithine aminotransferase from Plasmodium falciparum. Mol Biochem Parasitol. 2001;118(1):1–10.
   PubMed Web of Science ®Google Scholar
• Vieira L, Lavan A, Dagger F, et al. The role of anions in pH regulation of Leishmania major promastigotes. J Biol Chem. 1994;269(23):16254–16259.
   PubMed Web of Science ®Google Scholar
• Bayrhuber M, Meins T, Habeck M, et al. Structure of the human voltage-dependent anion channel. Proc Nat Acad Sci. 2008;105(40):15370–15375.
   PubMed Web of Science ®Google Scholar
• Lawen A, Ly JD, Lane DJ, et al. Voltage-dependent anion-selective channel 1 (VDAC1)—a mitochondrial protein, rediscovered as a novel enzyme in the plasma membrane. Int J Biochem Cell Biol. 2005;37(2):277–282.
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz V, Israelson A, Brdiczka D, et al. The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr Pharm Des. 2006;12(18):2249–2270.
   PubMed Web of Science ®Google Scholar
• Ponte-Sucre A, Campos Y, Fernandez M, et al. Leishmania sp.: growth and survival are impaired by ion channel blockers. Exp Parasitol. 1998;88(1):11–19.
   PubMed Web of Science ®Google Scholar
• Thuaud F, Ribeiro N, Nebigil CG, et al. Prohibitin ligands in cell death and survival: mode of action and therapeutic potential. Chem Biol. 2013;20(3):316–331.
   PubMedGoogle Scholar
• Almeida R, Gilmartin BJ, McCann SH, et al. Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome. Mol Biochem Parasitol. 2004;136(1):87–100.
   PubMed Web of Science ®Google Scholar
• Jain R, Ghoshal A, Mandal C, et al. Leishmania cell surface prohibitin: role in host–parasite interaction. Cell Microbiol. 2010;12(4):432–452.
   PubMed Web of Science ®Google Scholar
• Cruz-Bustos T, Ibarrola-Vannucci AK, Díaz-Lozano I, et al. Characterization and functionality of two members of the SPFH protein superfamily, prohibitin 1 and 2 in Leishmania major. Parasit Vectors. 2018;11(1):622.
   PubMedGoogle Scholar
• Garin J, Diez R, Kieffer S, et al. The phagosome proteome: insight into phagosome functions. J Cell Biol. 2001;152(1):165–180.
   PubMed Web of Science ®Google Scholar
• Dias DS, Ribeiro PA, Martins VT, et al. Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis. Cell Immunol. 2018;323:59–69.
   PubMed Web of Science ®Google Scholar
• Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305–318.
   PubMed Web of Science ®Google Scholar